Supplementary Data from Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine Versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast CancerCristina Saura,Judit Matito,Mafalda Oliveira,Hans Wildiers,Adam M. Brufksy,Simon H. Waters,Sara A. Hurvitz,Beverly Moy,Sung-Bae Kim,William J. Gradishar,Geraldo Silva Queiroz,Eduardo Cronemberger,Gerald J. Wallweber,Judith Bebchuk,Kiana Keyvanjah,Alshad S. Lalani,Richard Bryce,Ana Vivancos,Lisa D. Eli,Suzette Delalogecrossref（2024）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
